Surrey researchers Sign in
A blinded, randomized controlled trial of neo-adjuvant celecoxib in patients with early prostate cancer.
Conference presentation   Peer reviewed

A blinded, randomized controlled trial of neo-adjuvant celecoxib in patients with early prostate cancer.

P Sooriakumaran, P Macanas-Pirard, S Fox, H Coley, G Bucca, D Lovell, A Henderson, C Smith, S Langley and R Laing
JOURNAL OF CLINICAL ONCOLOGY, Vol.24(18), pp.232S-232S
42nd Annual Meeting of the American-Society-of-Clinical-Oncology (Atlanta, GA, 02/06/2006 - 06/06/2006)
20/06/2006

Abstract

Science & Technology Life Sciences & Biomedicine Oncology ONCOLOGY
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239009401362&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

23 Record Views

Details

Usage Policy